Aprio Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.31M Buy
15,143
+521
+4% +$45.9K 0.06% 200
2026
Q2
$1.14M Sell
14,622
-336
-2% -$27.1K 0.06% 211
2026
Q1
$1.3M Sell
14,958
-1,681
-10% -$161K 0.07% 158
2025
Q4
$1.6M Buy
16,639
+12,871
+342% +$1.25M 0.09% 142
2025
Q3
$359K Buy
+3,768
New +$346K 0.04% 287
2025
Q2
– Sell
-3,300
Closed -$297K – 423
2025
Q1
$297K Buy
+3,300
New +$295K 0.04% 270

Other funds holding MDT

Aprio Wealth Management's MDT Position: Q3 2026 in Review

Aprio Wealth Management increased its Medtronic (MDT) stake by 3.6% in Q3 2026, buying an estimated $45.9K and bringing the position to 15,143 shares worth $1.31M. The position accounts for 0.06% of the portfolio, ranked #200.

Aprio Wealth Management first reported a position in MDT in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.6M in Q4 2025. 1,279 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Aprio Wealth Management held 15,143 shares of Medtronic worth $1.31M as of Q3 2026.
  • Aprio Wealth Management bought 521 Medtronic shares in Q3 2026, an estimated $45.9K.
  • Medtronic made up 0.06% of Aprio Wealth Management's portfolio in Q3 2026, its #200 holding.
  • Aprio Wealth Management first reported a position in Medtronic in Q1 2025 and has held it in 6 quarters since.
  • Aprio Wealth Management's Medtronic position peaked at $1.6M in Q4 2025.
  • 1,279 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Aprio Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.